Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice

Behavioural Brain Research

Volumn 145, Issue 1-2, 2003, Pages 31-36

  Mehta, Hina ^a   Saravanan, Karuppagounder S ^a   Mohanakumar, Kochupurackal P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Behavior; Central control of motor dysfunction; Cerebellum; Harmaline; Olivary nucleus; Tremor; Tryptophan hydroxylase inhibition

Indexed keywords

ENZYME INHIBITOR; FENCLONINE; HARMALINE; SEROTONIN; TRYPTOPHAN HYDROXYLASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; MOUSE; NONHUMAN; OLIVARY NUCLEUS; PATHOGENESIS; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; TREMOR;

EID: 0141757425     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(03)00094-9     Document Type: Article

References (26)

1. Costall B., Kelly D.M., Naylor R.J. The importance of 5-hydroxytryptamine for the induction of harmine tremor and its antagonism by dopaminergic agonists assessed by lesions of the midbrain raphe nuclei. Eur. J. Pharmacol. 35:1976;109-119.
2. De Montigny C., Lamarre Y. Rhythmic activity induced by harmaline in the olive-cerebello-bulbar system of the cat. Brain Res. 53:1973;81-95.
3. Elble R.J. Animal models of action tremor. Mov. Disord. 13:1998;35-39.
4. Grahame-Smith D.G. Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with monoamine oxidase inhibitor and L-tryptophan. J. Neurochem. 18:1971;1053-1066.
5. Hallberg H., Carlsson H., Elg R. Objective quantification of tremor in conscious unrestrained rats, exemplified with 5-hydroxytryptamine-mediated tremor. J. Pharmacol. Methods. 18:1985;261-266.
6. Headley P.M., Lodge D., Duggan A.W. Drug-induced rhythmical activity in the inferior olivary complex of the rat. Brain Res. 101:1976;461-478.
7. Kawanishi K., Hashimoto Y., Fujiwara M., Kataoka Y., Ueki S. Pharmacological characteristics of abnormal behavior induced by harmine with special reference to tremor in mice. J. Pharmacobiodyn. 14:1981;520-527.
8. Kurtzke J.F. The current neurological burden of illness and injury in United States. Neurology. 32:1982;1207-1214.
9. Llinas R., Volkind R.A. The olivo-cerebellar system: functional properties as revealed by harmaline-induced tremor. Exp. Brain Res. 18:1973;69-87.
10. Lorden J.F., Stratton S.E., Mays L.E., Oltmans G.A. Purkinje cell activity in rats following chronic treatment with harmaline. Neuroscience. 27:1988;465-472.
11. Lutes J., Lorden J.F., Beales M., Oltmans G.A. Tolerance to the tremorogenic effects of harmaline: evidence for altered olivo-cerebellar function. Neuropharmacology. 27:1988;849-855.
12. Mehta H., Thomas B., Mohanakumar K.P. Effects of p-chlorophenylalanine on striatal acetylcholinesterase activity and on biogenic amine levels in nuclei raphe and caudate-putamen during physostigmine-induced tremor in rats. Neurosci. Lett. 299:2001;105-108.
13. Milner T.E., Cadoret G., Lessard L., Smith A.M. EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive. J. Neuropysiol. 73:1995;2568-2577.
14. Mohanakumar K.P., Ganguly D.K. Tremorogenesis by LON-954 [N-carbamoyl-2-(2,6-dichlorophenyl)] acetamidine hydrochloride: evidence for the involvement of 5-hydroxytryptamine. Brain Res. Bull. 22:1989;191-195.
15. Mohanakumar K.P., Mitra N., Ganguly D.K. Tremorogenesis by physostigmine is unrelated to acetylcholinesterase inhibition: evidence for serotoninergic involvement. Neurosci. Lett. 120:1990;91-93.
16. O'Hearn E., Molliver M.E. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience. 55:1993;303-310.
17. Sarkar S., Thomas B., Muralikrishnan D., Mohanakumar K.P. Effects of serotoninergic drugs on tremor induced by physostigmine in rats. Behav. Brain Res. 109:2000;187-193.
18. Shuto H., Kataoka Y., Kanaya A., Matsunaga K., Sueyasu M., Oishi R. Enhancement of serotonergic neural activity contributes to cyclosporine-induced tremors in mice. Eur. J. Pharmacol. 341:1998;33-37.
19. Sinclair J.G., Lo G.F., Harris D.P. Ethanol effects on the olivo-cerebellar system. Can. J. Physiol. Pharmacol. 60:1982;610-614.
20. Sjolund B., Bjorklund A., Wiklund L. The indolaminergic innervation of the inferior olive. 2. Relation to harmaline-induced tremor. Brain Res. 131:1977;23-37.
21. Stanford J.A., Fowler S.C. At low doses, harmaline increases forelimb tremor in the rat. Neurosci. Lett. 241:1998;41-44.
22. Tariq M., Arshaduddin M., Biary N., Al Moutaery K., Al Deeb S. Baclofen attenuates harmaline-induced tremors in rats. Neurosci. Lett. 312:2001;79-82.
23. Welsh J.P., Chang B., Menaker M.E., Aicher S.A. Removal of the inferior olive abolishes myoclonic seizures associated with a loss of olivary serotonin. Neuroscience. 82:1998;879-897.
24. Wiklund L., Sjolund B., Bjorklund A. Morphological and functional studies on the serotoninergic innervation of the inferior olive. J. Physiol. (Paris). 77:1981;183-186.
25. Wilms H., Sievers J., Deuschl G. Animal models of tremor. Mov. Disord. 14:1999;611-613.
26. Yarom Y., Llinas R. Long-term modifiability of anomalous and delayed rectification in guinea pig inferior olivary neurons. J. Neurosci. 7:1987;1166-1177.